Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
4
×
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
study
4
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
celgene
clinical trial
fail
heart disease
nash
prescriptions
sanofi
2025
acc
acquisition
activist investor
ad-comm
What
new
bio
cancer
depression
drug
medical
roundup
adu
allogene
approved
beats
bids
biogen
centers
cholesterol
complicated
crispr
cut
dire
diversity
drugs
event
expensive
faces
financial
foe
genetic
good
group
guesswork
guide
healthcare
heart
help
helps
hint
hot
immunotherapy
inhibitors
investors
Language
unset
Current search:
study
×
national
×
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
Will New Study Cut Guesswork for Depression Medicine Prescriptions?
